These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25993193)

  • 1. Comparative effectiveness research in cancer with observational data.
    Giordano SH
    Am Soc Clin Oncol Educ Book; 2015; ():e330-5. PubMed ID: 25993193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
    Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
    Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for observational research using large data sets in radiation oncology.
    Jagsi R; Bekelman JE; Chen A; Chen RC; Hoffman K; Shih YC; Smith BD; Yu JB
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):11-24. PubMed ID: 25195986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
    Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-Based Observational Studies in Oncology: Proceed With Caution.
    Soni PD; Spratt DE
    Semin Radiat Oncol; 2019 Oct; 29(4):302-305. PubMed ID: 31472729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological issues in observational studies and non-randomized controlled trials in oncology in the era of big data.
    Tanaka S; Tanaka S; Kawakami K
    Jpn J Clin Oncol; 2015 Apr; 45(4):323-7. PubMed ID: 25589456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness clinical trials to advance treatment of myasthenia gravis.
    Guptill JT; Raja S; Sanders DB; Narayanaswami P
    Ann N Y Acad Sci; 2018 Feb; 1413(1):69-75. PubMed ID: 29377158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instrumental variable analyses for observational comparative effectiveness research: the paired availability design.
    Garabedian LF; Zaslavsky AM; Soumerai SB
    Ann Intern Med; 2014 Dec; 161(11):841. PubMed ID: 25437418
    [No Abstract]   [Full Text] [Related]  

  • 9. Instrumental variable analyses for observational comparative effectiveness research: the paired availability design.
    Baker SG; Lindeman KS
    Ann Intern Med; 2014 Dec; 161(11):840-1. PubMed ID: 25437417
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-study feasibility and identifying sensitivity analyses for protocol pre-specification in comparative effectiveness research.
    Girman CJ; Faries D; Ryan P; Rotelli M; Belger M; Binkowitz B; O'Neill R;
    J Comp Eff Res; 2014 May; 3(3):259-70. PubMed ID: 24969153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness research in oncology methodology: observational data.
    Hershman DL; Wright JD
    J Clin Oncol; 2012 Dec; 30(34):4215-22. PubMed ID: 23071228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performing both propensity score and instrumental variable analyses in observational studies often leads to discrepant results: a systematic review.
    Laborde-Castérot H; Agrinier N; Thilly N
    J Clin Epidemiol; 2015 Oct; 68(10):1232-40. PubMed ID: 26026496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian data analysis in observational comparative effectiveness research: rationale and examples.
    Olson WH; Crivera C; Ma YW; Panish J; Mao L; Lynch SM
    J Comp Eff Res; 2013 Nov; 2(6):563-71. PubMed ID: 24236795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent biases in observational studies of comparative effectiveness research in rheumatology. A methodological review.
    Iudici M; Porcher R; Riveros C; Ravaud P
    Ann Rheum Dis; 2019 Apr; 78(4):562-569. PubMed ID: 30755417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.
    Johnson ML; Crown W; Martin BC; Dormuth CR; Siebert U
    Value Health; 2009; 12(8):1062-73. PubMed ID: 19793071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research.
    Moss HA; Melamed A; Wright JD
    Gynecol Oncol; 2019 Mar; 152(3):533-539. PubMed ID: 30876500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational studies in systematic [corrected] reviews of comparative effectiveness: AHRQ and the Effective Health Care Program.
    Norris SL; Atkins D; Bruening W; Fox S; Johnson E; Kane R; Morton SC; Oremus M; Ospina M; Randhawa G; Schoelles K; Shekelle P; Viswanathan M
    J Clin Epidemiol; 2011 Nov; 64(11):1178-86. PubMed ID: 21636246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of observational investigations in comparative effectiveness research.
    Marko NF; Weil RJ
    Value Health; 2010 Dec; 13(8):989-97. PubMed ID: 21138497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice-based evidence research in rehabilitation: an alternative to randomized controlled trials and traditional observational studies.
    Horn SD; DeJong G; Deutscher D
    Arch Phys Med Rehabil; 2012 Aug; 93(8 Suppl):S127-37. PubMed ID: 22840879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.
    Berger ML; Mamdani M; Atkins D; Johnson ML
    Value Health; 2009; 12(8):1044-52. PubMed ID: 19793072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.